1 Min Read
July 13 (Reuters) - Biohaven Pharmaceutical Holding Company Ltd:
* Biohaven receives notice of allowance from U.S. Patent and trademark office on patent application for glutamate modulating prodrugs Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.